SUNNYVALE, Calif., April 09, 2024 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced it will report financial results for the first quarter 2024 after market close on Tuesday, April 30 th , 2024. Company management will host a corresponding audio webcast beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time.

https://www.investing.com/news/company-news/lake-street-boosts-target-for-silk-road-medical-shares-optimistic-on-growth-strategy-93CH-3363996

No summary available.

https://www.investing.com/news/stock-market-news/silk-road-medical-stock-upgraded-at-argus-sees-12-revenue-growth-93CH-3328517

SUNNYVALE, Calif., March 05, 2024 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced that it has launched its Tapered ENROUTE Transcarotid Stent System to hospitals in the United States. This launch expands upon the company’s prior ENROUTE Transcarotid Stent System, offering additional configurations Jetzt den vollständigen Artikel lesen

https://www.investing.com/news/stock-market-news/earnings-call-silk-road-medical-reports-robust-growth-eyes-international-markets-93CH-3321977

No summary available.

Silk Road Medical (NASDAQ: SILK ) reported its Q4 earnings results on Wednesday, February 28, 2024 at 04:05 PM. Here''s what investors need to know about the announcement. Earnings Silk Road Medical beat estimated earnings by 21.0%, reporting an EPS of $-0.33 versus … Full story available on Benzinga.com

SUNNYVALE, Calif., Feb. 28, 2024 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today reported financial results for the three months and full year ended December 31, 2023.

No summary available.